Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets. (2022)
Attributed to:
Multiscale Metrology Suite for Next-Generation Health Nanotechnologies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12885-022-09969-4
PubMed Identifier: 35948941
Publication URI: http://europepmc.org/abstract/MED/35948941
Type: Journal Article/Review
Volume: 22
Parent Publication: BMC cancer
Issue: 1
ISSN: 1471-2407